The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)
- Conditions
- Cancer, Advanced
- Interventions
- Other: Hospital day care follow-up
- Registration Number
- NCT04604873
- Lead Sponsor
- Institut Curie
- Brief Summary
The main objective is to show the impact on the quality of life (QoL) for adults patients with advanced cancer managed in day hospital of integrated palliative care of cancer center (HDJ-SPI).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 144
- Patient ≥ 18 years old with advanced solid tumor
- Addressed for the first time to the palliative care team according to current criteria (medico-psycho-social symptoms, progressive risks)
- With or without anti-cancer treatment
- With estimated life expectancy of more than 2 months and less than 12 months
- Able to communicate in French and answer questionnaires
- Affiliated with a social security system
- Having signed informed consent, co-signed by the partner if designated by the patient
- Patient with primitive brain tumor or malignant hemopathy
- Severe psychopathological disorders
- Pregnant patient or childbearing potential without effective method of birth control
- Unable to be followed at the cancer center until death
- Patient deprived of liberty or under guardianship -
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hospital one day care Hospital day care follow-up Hospital one day care
- Primary Outcome Measures
Name Time Method Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer 12 months Analyse impact of hospital day care in integrated palliative care department on quality of life of adult patients with advanced stage cancer
Outcome shall be evaluated by assessing Survival without quality of life deterioration,measured by EORTC QLQ-C30 scale with monthly evaluation targeting three dimensions :
global quality of life/ fatigue/ patient emotional state
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
Institut de Cancerologie de L'Ouest
🇫🇷Saint-herblain, France
Institutcurie Paris
🇫🇷Paris, France
Institut Bergonie
🇫🇷Bordeaux, France
Centre Antoine Lacassagne
🇫🇷Nice, France
INSTITUT CURIE Saint-Cloud
🇫🇷Saint-cloud, France
Centre Paul Strauss
🇫🇷Strasbourg, France